Atlas Trials

Phase I Trial of Measles Vectored Chikungungya Vaccine

Clinical trial NCT03028441 · COMPLETED

Trial details

NCT number
NCT03028441
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Chikungunya Virus Infection
Start date
2017-05-30
Primary completion
2019-01-17
Enrollment
180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.